Search Results

There are 16343 results for: content related to: Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

  1. Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study

    The Journal of Dermatology

    Volume 41, Issue 12, December 2014, Pages: 1039–1046, Mamitaro Ohtsuki, Akimichi Morita, Masatoshi Abe, Hidetoshi Takahashi, Noriko Seko, Alexander Karpov, Tomohiro Shima, Charis Papavassilis, Hidemi Nakagawa and forthe ERASURE Study Japanese subgroup

    Article first published online : 30 OCT 2014, DOI: 10.1111/1346-8138.12668

  2. You have full text access to this OnlineOpen article
    Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 777–787, D. Thaçi, J. Humeniuk, Y. Frambach, R. Bissonnette, J.J. Goodman, S. Shevade, Y. Gong, C. Papavassilis and for the STATURE study group

    Article first published online : 16 MAY 2015, DOI: 10.1111/bjd.13814

  3. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

    British Journal of Dermatology

    Volume 172, Issue 2, February 2015, Pages: 484–493, A. Blauvelt, J.C. Prinz, A.B. Gottlieb, K. Kingo, H. Sofen, M. Ruer-Mulard, V. Singh, R. Pathan, C. Papavassilis, S. Cooper and for the FEATURE Study Group

    Article first published online : 11 DEC 2014, DOI: 10.1111/bjd.13348

  4. You have free access to this content
    Australasian College of Dermatologists Abstracts Presented at the 48th Annual Scientific Meeting 16–19 May 2015 Adelaide, South Australia

    Australasian Journal of Dermatology

    Volume 56, Issue S2, May 2015, Pages: 1–87,

    Article first published online : 2 APR 2015, DOI: 10.1111/ajd.12337

  5. You have full text access to this OnlineOpen article
    New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors

    Dermatologic Therapy

    Volume 28, Issue 4, July/August 2015, Pages: 179–193, Anthony A. Gaspari and Stephen Tyring

    Article first published online : 23 JUL 2015, DOI: 10.1111/dth.12251

  6. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 6, June 2015, Pages: 1082–1090, C. Paul, J.-P. Lacour, L. Tedremets, K. Kreutzer, S. Jazayeri, S. Adams, C. Guindon, R. You, C. Papavassilis and for the JUNCTURE study group

    Article first published online : 22 SEP 2014, DOI: 10.1111/jdv.12751

  7. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Article first published online : 5 NOV 2015, DOI: 10.1002/art.39448

  8. You have free access to this content
    Abstracts

    Internal Medicine Journal

    Volume 45, Issue S2, May 2015, Pages: 1–46,

    Article first published online : 10 MAY 2015, DOI: 10.1111/imj.12752

  9. You have free access to this content
    Poster

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue S1, April 2015, Pages: 111–185,

    Article first published online : 30 MAR 2015, DOI: 10.1111/ddg.12658

  10. Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1670–1675, C. Paul, K. Reich, A.B. Gottlieb, U. Mrowietz, S. Philipp, J. Nakayama, E. Harfst, A. Guettner, C. Papavassilis and for the CAIN457A2211 study group

    Article first published online : 7 JAN 2014, DOI: 10.1111/jdv.12359

  11. You have free access to this content
    47th Annual Scientific Meeting

    Australasian Journal of Dermatology

    Volume 55, Issue S1, May 2014, Pages: 1–58,

    Article first published online : 15 MAY 2014, DOI: 10.1111/ajd.12174

  12. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

    British Journal of Dermatology

    Volume 168, Issue 2, February 2013, Pages: 412–421, K.A. Papp, R.G. Langley, B. Sigurgeirsson, M. Abe, D.R. Baker, P. Konno, S. Haemmerle, H.J. Thurston, C. Papavassilis and H.B. Richards

    Article first published online : 18 JAN 2013, DOI: 10.1111/bjd.12110

  13. You have free access to this content
    Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis

    Immunology

    Volume 141, Issue 2, February 2014, Pages: 133–142, Bruce W. Kirkham, Arthur Kavanaugh and Kristian Reich

    Article first published online : 9 JAN 2014, DOI: 10.1111/imm.12142

  14. 7th International Congress of Psoriasis: from Gene to Clinic The Queen Elizabeth II Conference Centre, London, U.K. 11th-13th December 2014

    British Journal of Dermatology

    Volume 171, Issue 6, December 2014, Pages: e105–e173,

    Article first published online : 18 DEC 2014, DOI: 10.1111/bjd.13488

  15. Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials

    International Journal of Dermatology

    Bruce Strober, Bárður Sigurgeirsson, Georg Popp, Rodney Sinclair, James Krell, Sigitas Stonkus, Marcis Septe, Boni E. Elewski, Alice B. Gottlieb, Yang Zhao, Mary H. Tran, Alexander Karpov, Lori D. McLeod, Margaret Mordin, Charis Papavassilis, Judit Nyirady and Mark Lebwohl

    Article first published online : 11 FEB 2016, DOI: 10.1111/ijd.13236

  16. You have free access to this content
    Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion

    Experimental Dermatology

    Volume 25, Issue 2, February 2016, Pages: 157–159, Christian Dragatin, Florine Polus, Manfred Bodenlenz, Claudio Calonder, Birgit Aigner, Katrin Irene Tiffner, Julia Katharina Mader, Maria Ratzer, Ralph Woessner, Thomas Rudolf Pieber, Yi Cheng, Christian Loesche, Frank Sinner and Gerard Bruin

    Article first published online : 23 NOV 2015, DOI: 10.1111/exd.12863

  17. Psoriasis: rationale for targeting interleukin-17

    British Journal of Dermatology

    Volume 167, Issue 4, October 2012, Pages: 717–724, G. Girolomoni, U. Mrowietz and C. Paul

    Article first published online : 26 SEP 2012, DOI: 10.1111/j.1365-2133.2012.11099.x

  18. You have full text access to this OnlineOpen article
    Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis

    Experimental Dermatology

    Volume 24, Issue 7, July 2015, Pages: 529–535, Kristian Reich, Kim A. Papp, Robert T. Matheson, John H. Tu, Robert Bissonnette, Marc Bourcier, David Gratton, Rodion A. Kunynetz, Yves Poulin, Les A. Rosoph, Georg Stingl, Wolfgang M. Bauer, Janeen M. Salter, Thomas M. Falk, Norbert A. Blödorn-Schlicht, Wolfgang Hueber, Ulrike Sommer, Martin M. Schumacher, Thomas Peters, Ernst Kriehuber, David M. Lee, Grazyna A. Wieczorek, Frank Kolbinger and Conrad C. Bleul

    Article first published online : 8 MAY 2015, DOI: 10.1111/exd.12710

  19. You have free access to this content
    New treatment for tackling plaque psoriasis

    Prescriber

    Volume 26, Issue 20, 19 October 2015, Pages: 12–14, Steve Chaplin, Susan O'Gorman and Trevor Markham

    Article first published online : 13 OCT 2015, DOI: 10.1002/psb.1397

  20. Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis

    International Journal of Dermatology

    Volume 55, Issue 3, March 2016, Pages: e147–e155, Bruce Strober, Yang Zhao, Mary Helen Tran, Ari Gnanasakthy, Judit Nyirady, Charis Papavassilis, Lauren M. Nelson, Lori D. McLeod, Margaret Mordin, Alice B. Gottlieb, Boni E. Elewski and Mark Lebwohl

    Article first published online : 30 OCT 2015, DOI: 10.1111/ijd.13117